JCI vs WST · P/E 44, rev $23.60B vs P/E 35, rev $1.72B
Johnson Controls International PLC (JCI) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
JCI currently screens at market cap $87.62B and trailing P/E 43.9. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the JCI and WST stock pages for the full models.
Not investment advice.